Dextropropoxyphene
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00647 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | common cold | KG + DL |
| 3 | nasal cavity disease | KG + DL |
| 4 | pharyngitis | KG + DL |
| 5 | acute laryngopharyngitis | KG + DL |
| 6 | methemoglobinemia | KG + DL |
| 7 | exercise-induced malignant hyperthermia | KG + DL |
| 8 | headache disorder | KG + DL |
| 9 | trichotillomania | KG + DL |
| 10 | Tourette syndrome | KG + DL |
| 11 | gastroduodenitis | KG + DL |
| 12 | restless legs syndrome | KG + DL |
| 13 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 14 | trigeminal autonomic cephalalgia | KG + DL |
| 15 | manic bipolar affective disorder | KG + DL |
| 16 | open-angle glaucoma | KG + DL |
| 17 | nephrogenic diabetes insipidus | KG + DL |
| 18 | primary hereditary glaucoma | KG + DL |
| 19 | specific developmental disorder | KG + DL |
| 20 | familial periodic paralysis | KG + DL |
| 21 | schizophreniform disorder | KG + DL |
| 22 | allergic urticaria | KG + DL |
| 23 | hypokalemic periodic paralysis | KG + DL |
| 24 | methemoglobinemia, alpha type | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.